Zoetis buys VitalRADS to extend its animal-health platform beyond the test result

28/08/2026

Zoetis completed the acquisition of veterinary teleradiology platform VitalRADS in July, linking specialist imaging interpretation to its expanding diagnostics business. The deal is strategically notable because it shifts the value proposition from selling discrete diagnostic tools toward a more connected service model: image capture, cloud storage, specialist review, AI-assisted workflow and results delivery. In a companion-animal market where clinic demand has been under pressure, that broader workflow position may matter as much as any single test.

VitalRADS provides teleradiology, mobile ultrasound, outpatient imaging and cloud image storage. At the time Zoetis announced the agreement on 14 July, it said the business provided around-the-clock access to board-certified specialists, same-day results and two-hour STAT reads. Its platform served more than 1,800 active customers, including corporate and independent practices and universities. Zoetis said the transaction would extend its Global Diagnostics business beyond in-vitro testing and help build a more complete Virtual Reference Lab. Financial terms were not disclosed.

The acquisition came into focus in Zoetis’ second-quarter results on 6 August. Revenue was flat at $2.5 billion, while reported net income was $691 million. The company cited a more pressured companion-animal market, with lower clinic visits, price sensitivity and stronger competition in parts of the portfolio. It revised its 2026 revenue guidance to $9.12 billion to $9.32 billion, implying organic operational revenue growth of minus 3% to minus 1%.

The commercial logic seems clear. When medication demand is softer, owning a larger share of the diagnostic workflow can support relevance with practices through productivity, turnaround and clinical-decision support rather than relying solely on product volume. The transaction also puts Zoetis closer to the data-rich layer of veterinary care. That is not a promise of immediate financial uplift, but it strengthens the company’s ability to bundle services, deepen customer relationships and invest where AI and specialist capacity can reduce friction for veterinary teams.

For further information > Zoetis